Background: Cancer is the most common cause of disease-related death in children, adolescents, and young adults in high-income countries. In Norway, leukemia, non-Hodgkin lymphoma and cancer in the central nervous system are the most common cancers among children. These represent nearly 60% of all cancer cases in boys and girls. Hodgkin’s lymphoma accounts for about 10% of all lymphomas and the remaining 90% are referred to as non-Hodgkin lymphoma (NHL). Objective: The main objective of this study was to investigate late effects of cancer among survivors of NHL diagnosed at the age 18-35 years in Norway. Methods: Nationwide longitudinal register-based study investigating General practitioners (GPs) consultations among adolescents, and young...
PURPOSE: Hodgkin lymphoma (HL) survivors experience high risks of second cancers and cardiovascular ...
Background: Although uncommon in teenagers and young adults, cancer is the leading cause of non-acci...
Background: Hodgkin lymphoma (HL) treatment protocols for children, adolescents and young adults tra...
INTRODUCTION:Survival rates of cancer patients have generally improved in recent years. However, chi...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
In the present study, we report on the full range of physical diseases acquired by survivors of Hodg...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
The burden of late effects among Hodgkin lymphoma (HL) survivors treated according to contemporary p...
Background: Hodgkin's lymphoma (HL) constitutes 10%-20% of all malignant lymphomas and has a high cu...
Purpose: Health care needs of adolescents and young adults (AYAs) with cancer are probably different...
<div><p>Introduction</p><p>Survival rates of cancer patients have generally improved in recent years...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
This is the author accepted manuscript. The final version is available from Royal College of General...
PURPOSE: Hodgkin lymphoma (HL) survivors experience high risks of second cancers and cardiovascular ...
Background: Although uncommon in teenagers and young adults, cancer is the leading cause of non-acci...
Background: Hodgkin lymphoma (HL) treatment protocols for children, adolescents and young adults tra...
INTRODUCTION:Survival rates of cancer patients have generally improved in recent years. However, chi...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
In the present study, we report on the full range of physical diseases acquired by survivors of Hodg...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
The burden of late effects among Hodgkin lymphoma (HL) survivors treated according to contemporary p...
Background: Hodgkin's lymphoma (HL) constitutes 10%-20% of all malignant lymphomas and has a high cu...
Purpose: Health care needs of adolescents and young adults (AYAs) with cancer are probably different...
<div><p>Introduction</p><p>Survival rates of cancer patients have generally improved in recent years...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
This is the author accepted manuscript. The final version is available from Royal College of General...
PURPOSE: Hodgkin lymphoma (HL) survivors experience high risks of second cancers and cardiovascular ...
Background: Although uncommon in teenagers and young adults, cancer is the leading cause of non-acci...
Background: Hodgkin lymphoma (HL) treatment protocols for children, adolescents and young adults tra...